Chile Selects DxCG RiskSmart for National Health Risk Management Program

January 1, 2011 / 2 min read

WALTHAM, Mass., April 21, 2009 — Verisk Health, Inc., a leading global healthcare data analytics firm that delivers solutions to minimize medical and financial risk, today announced that Chile’s Health Superintendency has licensed Verisk Health’s DxCG RiskSmart® Stand Alone software for a pilot program to implement risk adjustment in the management of Chile’s large private insurer funds, Isapres (Instituciones de Salud Previsional).

Chile’s Health Superintendency is responsible for fiscal control of the nation’s health systems. The agency is seeking to improve its predictive capabilities and provide technical tools to facilitate a new risk-adjustment formula that considers disease status (morbidity) as a risk-adjustment factor.

“We are extremely pleased to be selected by Chile’s Health Superintendency to identify and manage risk for Isapres,” said Mike Coyne, executive vice president of Verisk Health. “By providing effective tools to governments faced with the intricate challenges of health resource allocation, we continue to expand our proven reputation for achieving the most innovative science-based healthcare risk-management solution in the industry.”

DxCG RiskSmart Stand Alone combines science and technology to deliver detailed predictions around cost and care. It integrates seamlessly with existing data to offer an extensive selection of best-of-class predictive models, automatically transforming data into summarized clinical profiles, assigning risk scores, and making predictions of resource use or illness burden for individuals and populations.

About Verisk Health
Verisk Health leverages healthcare data to help businesses understand their medical and financial risk to better manage costs and clinical outcomes. By combining the leading predictive science with the finest evidence-based clinical engine, and powering it with superior technology, we have created the most extensive independent risk-assessment and decision-analytics platform in the healthcare industry. Our complete focus is on identifying actionable strategies for managing healthcare costs and quality at both the individual and population levels. By growing and investing in our own business, we have become agents of change in our clients’ businesses and in the industry. Verisk Health is a wholly owned subsidiary of ISO. For more information, please visit www.veriskhealth.com.

Release: Immediate

Contact:
Rosa Randazzo
Marketing Associate
Verisk Health
781-693-3739
rrandazzo@veriskhealth.com